Application 077624
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLIMEPIRIDE | GLIMEPIRIDE | TABLET;ORAL | 1MG | No | No |
| 002 | GLIMEPIRIDE | GLIMEPIRIDE | TABLET;ORAL | 2MG | No | No |
| 003 | GLIMEPIRIDE | GLIMEPIRIDE | TABLET;ORAL | 4MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077624-001 | GLIMEPIRIDE | GLIMEPIRIDE | 1MG | TABLET / ORAL | 2005-11-28 | ||
| A077624-002 | GLIMEPIRIDE | GLIMEPIRIDE | 2MG | TABLET / ORAL | 2005-11-28 | ||
| A077624-003 | GLIMEPIRIDE | GLIMEPIRIDE | 4MG | TABLET / ORAL | 2005-11-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077624-001 | GLIMEPIRIDE | 1MG | TABLET / ORAL | 2005-11-28 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A077624-002 | GLIMEPIRIDE | 2MG | TABLET / ORAL | 2005-11-28 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A077624-003 | GLIMEPIRIDE | 4MG | TABLET / ORAL | 2005-11-28 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glimepiride | GLIMEPIRIDE | St. Mary's Medical Park Pharmacy | fc9d8495-184c-3af1-e053-6394a90a5e29 | 2026-06-22 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | Bryant Ranch Prepack | 9e863f84-d6f2-4d61-8250-774569e84353 | 2026-05-19 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | Cardinal Health 107, LLC | cc2bc07f-3fab-4df1-85cc-dc0c8e60b4fa | 2026-05-08 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | Preferred Pharmaceuticals Inc. | f69e36b9-4940-4f01-b5ea-59dc66dc1e87 | 2026-05-06 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | Preferred Pharmaceuticals Inc. | 744a5cca-7863-491a-b43a-1b649791702c | 2026-05-06 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | Bryant Ranch Prepack | 248c3cb3-4501-4b85-bd1d-0624b6afda2c | 2026-04-13 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | Bryant Ranch Prepack | 90d675cb-6def-49a3-b8b4-229f19d6b617 | 2026-04-13 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | PD-Rx Pharmaceuticals, Inc. | 647a146c-c752-4589-8619-aed5c720ca54 | 2026-03-19 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | PD-Rx Pharmaceuticals, Inc. | ed7a3a8e-97dd-4a5a-9497-001acfd2f1f0 | 2026-03-19 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | Aurobindo Pharma Limited | 28eefc95-d92e-4555-b6c5-2933860b0610 | 2026-03-18 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | Bryant Ranch Prepack | 62780d2e-083d-4bcb-99ff-1b1b4ade60d9 | 2026-03-09 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | PD-Rx Pharmaceuticals, Inc. | 1450f455-a14a-4f9b-b3aa-dae49ea0c186 | 2026-02-26 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | NuCare Pharmaceuticals,Inc. | bf8e5993-5ee7-d26d-e053-2a95a90ae5df | 2026-02-19 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | Proficient Rx LP | dbed06f9-7758-4c96-9af0-1ed6103db7df | 2026-02-01 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | Proficient Rx LP | e12ab052-e3d6-4246-b727-f1e3f9057f09 | 2026-02-01 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | Coupler LLC | 41bf4a72-9288-50a1-e063-6394a90a5e7c | 2026-01-19 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | Rising Pharma Holdings, Inc. | 48ada723-8144-497d-afd6-a8c52a1dd3ff | 2026-01-19 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | AvPAK | 93f1e064-fcbd-e8fd-e053-2995a90a5dbb | 2026-01-14 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | PD-Rx Pharmaceuticals, Inc. | 58c4261e-e98f-4280-9562-2800956dff14 | 2026-01-07 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
| Glimepiride | GLIMEPIRIDE | PD-Rx Pharmaceuticals, Inc. | 1b3c7d74-f80b-4fb1-8dca-66880af5d3fc | 2026-01-07 | Warnings, Adverse reactions | Glimepiride GLIMEPIRIDE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-4011 | Glimepiride | glimepiride | Mylan Pharmaceuticals Inc | ANDA | Current |
| 0378-4011 | Glimepiride | glimepiride | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-4012 | Glimepiride | glimepiride | Mylan Pharmaceuticals Inc | ANDA | Current |
| 0378-4012 | Glimepiride | glimepiride | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-4013 | Glimepiride | glimepiride | Mylan Pharmaceuticals Inc | ANDA | Current |
| 0378-4013 | Glimepiride | glimepiride | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 51079-425 | Glimepiride | glimepiride | Mylan Institutional Inc. | ANDA | Current |
| 51079-425 | Glimepiride | glimepiride | Mylan Institutional Inc. | ANDA | Current |
| 51079-426 | Glimepiride | glimepiride | Mylan Institutional Inc. | ANDA | Current |
| 51079-426 | Glimepiride | glimepiride | Mylan Institutional Inc. | ANDA | Current |
| 55154-5070 | Glimepiride | glimepiride | Cardinal Health | ANDA | Current |